AKT1 and cancer: Among the dysregulation of multiple cell signaling cascades, the constitutive activation of the phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signaling axis and its downstream target molecule, the mechanistic target of rapamycin (mTOR), is commonly observed in many cancers [6].